PepCalcs
    Back to Library

    Triple Threat Blend

    Research Use OnlyEach component is in preclinical or early clinical research individually; the blend itself is investigational and not FDA approved.

    NAD+, MOTS-c, and 5-Amino-1MQ Blend

    Description

    A synergistic combination targeting mitochondrial function, cellular energy, and fat metabolism. Combines NAD+ precursor with mitochondrial peptide and NNMT inhibitor for comprehensive metabolic support.

    Dose:10 mg/1mg/1mg
    Frequency:3-4 days per week (8 weeks on/off cycle)
    Administration Method: SQ
    CategoryWeight Loss
    Half-LifeVaries by component: NAD+ minutes-hours; MOTS-c hours; 5-Amino-1MQ several hours.

    Overview

    The Triple Threat (NAD+ / MOTS-c / 5-Amino-1MQ) blend is marketed by research suppliers as a synergistic stack for mitochondrial energy, metabolic health, and longevity research. NAD+ replenishes a key redox cofactor, MOTS-c activates AMPK to enhance mitochondrial efficiency and insulin sensitivity, and 5-Amino-1MQ inhibits NNMT to preserve cellular NAD+ and methyl donors.

    Mechanism of Action

    Combination blend of NAD+ (sirtuin/PARP cofactor supporting cellular energy), MOTS-c (mitochondrial-derived peptide activating AMPK and improving glucose homeostasis), and 5-Amino-1MQ (NNMT inhibitor preserving NAD+ and methyl donors). The three converge on mitochondrial function, cellular energy, and metabolic regulation.

    Benefits

    • •Cellular energy
    • •Fat loss
    • •Mitochondrial support
    • •Metabolic enhancement

    Reported Side Effects

    • •Flushing (NAD+)
    • •Nausea
    • •Injection site reactions
    • •Limited long-term human data

    Safety Notes

    No clinical trials on the combined blend. Component-level safety data is limited. Research use only.

    Scientific References

    PubChem (NIH)Wikipedia

    Related Weight Loss Peptides

    Tesofensine

    Tesofensine

    A serotonin-norepinephrine-dopamine reuptake inhibitor originally studied as an anti-obesity agent. Promotes weight loss through appetite suppression.

    0.25-1 mg

    AOD-9604

    Anti-Obesity Drug 9604

    A synthetic peptide analog of natural AOD-9604 fragment that stimulates lipolysis and inhibits lipogenesis without affecting IGF-1 or insulin.

    300 mcg

    5-Amino-1MQ

    5-Amino-1-Methylquinolinium

    A small molecule that inhibits NNMT enzyme, boosting NAD+ levels and cellular energy. Supports fat loss and metabolic function.

    1 mg

    Ipamorelin/CJC-1295 No DAC

    Ipamorelin and CJC-1295 without DAC Blend

    A powerful synergistic combination of growth hormone secretagogues. Ipamorelin provides selective GH release while CJC-1295 extends GH pulse duration for enhanced fat loss and recovery.

    250 mcg each